Coya Therapeutics, Inc. Common Stock (COYA)
Healthcare
Biotechnology
4.20 $
+2.7%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Coya Therapeutics, Inc. Common Stock (COYA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.8% of the shares are freely tradable; institutional investors hold 35.4%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
35.4%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
14.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
74.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
4.3%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
24Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| AIGH Capital Management, LLC | 4.16 | 975,404 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 3.83 | 899,140 | +7.5 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.60 | 844,913 | +0.0 | 03/31/2026 |
| Alyeska Investment Group, L.P. | 3.41 | 800,000 | +0.0 | 03/31/2026 |
| Prosight Management, LP | 1.79 | 420,360 | +0.0 | 03/31/2026 |
| CM Management, LLC | 1.60 | 375,000 | +7.1 | 03/31/2026 |
| Private Management Group Inc | 1.57 | 369,096 | +31.7 | 03/31/2026 |
| Geode Capital Management, LLC | 1.00 | 233,402 | +17.9 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 0.96 | 225,792 | +0.2 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.56 | 601,117 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.